Clinical Evaluation of the Xpert® HIV-1 VL

NCT02461576 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 966

Last updated 2018-02-06

No results posted yet for this study

Summary

Compare the clinical performance of the Xpert® HIV-1 VL to another FDA approved HIV-1 RNA quantitative assay using frozen and fresh specimens from known HIV-1 positive individuals.

Conditions

  • Human Immunodeficiency Virus

Interventions

DEVICE

Xpert HIV-1 VL Assay

in vitro diagnostic test to quantify HIV-1 RNA

Sponsors & Collaborators

  • Cepheid

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2017-02-24
Completion
2017-02-24

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02461576 on ClinicalTrials.gov